Canton Strategic Holdings Reports First Quarter 2026 Financial and Operational Results Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Update Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer Tharimmune Elects Jill Sommers and William Wiley to Board of Directors Tharimmune Announces Expanded Role as Super Validator on Canton Network Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy Tharimmune, Inc. Announces Private Placement of Approximately $540 Million Led by DRW and Liberty City Ventures to Establish Canton Coin Treasury Strategy